Eight Sleep Hires Former Peloton Global Chief Sales Officer, Tim Shannehan, As New Chief Revenue Officer
Tim Shannehan, who spent 8 years at Peloton, joins the sleep fitness company to deliver…
Month: November 2022
Merchants & Marine Bank Selects KlariVis As Data Partner
ROANOKE, Va–(BUSINESS WIRE)–KlariVis, a fast-growing enterprise dashboard and analytics solution for the financial services industry,…
Q2 and CloudKaptan Help Prompt Financial Solutions Drive Growth by Transforming the Lending Experience
Ontario-based digital home lender Prompt Financial Solutions attracts more than 6,000 mortgage brokers and increases…
Ambient Photonics Breaks Ground on First-of-its-Kind, High-Volume Manufacturing Facility for Energy Harvesting Technology in California
Highly-accelerated build schedule supports surging demand for novel IoT climate tech solutions SCOTTS VALLEY, Calif.–(BUSINESS…
Crank That Metaverse Boombox: Authentic Artists and Yuga Labs Team Up to Bring WarpSound’s Generative AI Music to the Meebits Community
The leading creative AI-driven metaverse music platform from WarpSound powers the new Meebin Boombox with…
Goldman Sachs, MSCI, and Coin Metrics Collaborate to Introduce Datonomy™, a Taxonomy of Digital Assets
The new framework for digital assets classification is designed to provide investors, service providers, developers,…
Welldoc Chief Analytics Officer Anand Iyer, PhD, MBA Receives Global Innovator Award at International Summit Focused on Digital Health
COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that Anand Iyer,…
Experienced SBA Business Development Officer Joins First Internet Bank
FISHERS, Ind.–(BUSINESS WIRE)–#SBA–First Internet Bank announced today that Ben Rosensweet has joined the organization as…
DeepSee.ai Inducted into JPMorgan Chase’s Hall of Innovation
Fintech Startup Recognized for Delivering Efficiencies in Bank’s Global Markets Operations SALT LAKE CITY–(BUSINESS WIRE)–DeepSee.ai,…
Hayward Holdings to Participate in the Baird Global Industrial Conference
CHARLOTTE, N.C.–(BUSINESS WIRE)–Hayward Holdings, Inc. (NYSE: HAYW) (“Hayward”) a global designer, manufacturer, and marketer of…
CRISPR Therapeutics Announces Poster Presentation on CTX110® at the American Society of Hematology (ASH) 2022 Annual Meeting
ZUG, Switzerland and BOSTON, Nov. 03, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Company to host KOL conference call and webcast on Monday, December 12 at 5:00 p.m….
Vincerx Pharma Announces Upcoming Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting 2022
PALO ALTO, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
Oncternal Therapeutics to Present Updated Interim Phase 1/2 Data for Zilovertamab in Combination with Ibrutinib in an Oral Session at ASH 2022
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting
Poster presentation to highlight preclinical data for SENTI-202 which employs Logic Gating gene circuit technology…
Neoleukin Therapeutics Announces Oral Presentation at 64th American Society of Hematology (ASH) Annual Meeting
SEATTLE, Nov. 03, 2022 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company…
Cogent Biosciences Announces Bezuclastinib Presentations at the 64th Annual American Society of Hematology (ASH) Meeting
Company to Host Virtual Investor Event on Monday, December 12 WALTHAM, Mass. and BOULDER, Colo.,…
Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting
In 24 patients with CD30-positive lymphoma treated at the highest dose level, the combination treatment…
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
– Data from T cell Engager Portfolio for Hematologic Malignancies, Including First Preclinical Data for…
Apellis to Present New Long-Term Data Reinforcing the Robust Efficacy and Safety Profile of EMPAVELI® (pegcetacoplan) in PNH Patients at 2022 ASH Annual Meeting
Robust improvements in key markers of disease sustained across a broad population of adults with…